Quantcast

Latest Lilly Stories

2014-07-24 08:32:07

INDIANAPOLIS, July 24, 2014 /PRNewswire/ -- -- Second-quarter 2014 revenue declined 17 percent driven by the impact of U.S.

2014-07-10 12:28:42

INDIANAPOLIS, July 10, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has rebooted the Lilly for Better Health(TM) program, with several innovative enhancements to

2014-07-07 08:28:53

BEIJING, July 7, 2014 /PRNewswire/ -- Yabao Pharmaceutical Co, Inc.

2014-06-27 08:25:26

First biosimilar insulin to receive CHMP positive opinion in the EU INDIANAPOLIS and INGELHEIM, Germany, June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human

2014-06-27 08:25:19

First biosimilar insulin to receive CHMP positive opinion in the EU INDIANAPOLIS and RIDGEFIELD, Conn., June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human

2014-06-23 08:28:27

Anthem Blue Cross and Blue Shield and Indiana Family & Social Services Administration (FSSA)offer students insights on access to healthcare INDIANAPOLIS, June 23, 2014 /PRNewswire/

2014-06-16 20:22:11

AWARD-2: Once-Weekly Dulaglutide 0.75 mg Non-Inferior, 1.5 mg Superior in HbA1c Reduction from Baseline with Sustained Weight Loss and Lower Risk for Hypoglycemia SAN FRANCISCO, June 16, 2014

2014-06-14 12:20:45

Once-Weekly Dulaglutide 1.5 mg Also Demonstrates Weight Loss, Low Rates of Hypoglycemia in AWARD-6 Trial SAN FRANCISCO, June 14, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today

2014-06-14 12:20:40

Companies present comprehensive data for LY2963016, investigational new insulin glargine product SAN FRANCISCO, June 14, 2014 /PRNewswire/ -- For the first time today, Eli Lilly and Company

2014-06-11 08:29:11

INDIANAPOLIS, June 11, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the Phase III REACH trial of CYRAMZA(TM) (ramucirumab) in patients with hepatocellular carcinoma,


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.